Anti-Myostatin [Myo2/1A]

Clone Myo 2/1A has been shown to have the reverse effect, up-regulate myogenesis and down-regulate adipogenesis.

Contributors

Institute
BioServ UK Ltd
Cat. #: 153655
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cell signaling and signal transduction
Application: WB
Target: Myostatin
Reactivity: Human
Clone: Myo2/1A
Host: Mouse
Class: Monoclonal
Alternate name: Growth/differentiation factor 8, GDF-8, myostatin, GDF8, MSTN
Product description: Myostatin is a well-characterized negative regulator of skeletal muscle and can inhibit myogenesis and stimulate adipogenesis. Clone Myo 2/1A has been shown to have the reverse effect, up-regulate myogenesis and down-regulate adipogenesis.
Conjugation: Unconjugated
Molecular weight: 52 kDa
Immunogen: Recognizes the 113 amino acid carboxy-terminal fragment of Myostatin protein
Myeloma used: Sp2/0-Ag14
Target background: Myostatin is a well-characterized negative regulator of skeletal muscle and can inhibit myogenesis and stimulate adipogenesis. Clone Myo 2/1A has been shown to have the reverse effect, up-regulate myogenesis and down-regulate adipogenesis.
Format: Liquid
Shipping conditions: Dry ice
References:

Artaza et al. 2005. Endocrinology. 146(8):3547-57. PMID: 15878958.

Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells.

Images

View Gallery

Related Tools for Antibodies

Cat. # Tool Name
151021 Anti-CyclinB1 [V152] Key Info View Tool
151031 Anti-RuvA [RuvA 12C6] Key Info View Tool
151034 Anti-HSVUL42 [13D11] Key Info View Tool
151036 Anti-ICAM1 [15.2] Key Info View Tool
151017 Anti-MBP [R29.6] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.